Beta-Cell Dedifferentiation in Type 2 Diabetes: Concise Review

50Citations
Citations of this article
91Readers
Mendeley users who have this article in their library.

Abstract

Type 2 diabetes (T2D) is caused by an inherited predisposition to pancreatic islet β-cell failure, which is manifested under cellular stress induced by metabolic overload. The decrease in the functional β-cell mass associated with T2D has been attributed primarily to β-cell death; however, studies in recent years suggested that β-cell dedifferentiation may contribute to this decline. The mechanisms linking genetic factors and cellular stress to β-cell dedifferentiation remain largely unknown. This study evaluated the evidence for β-cell dedifferentiation in T2D, and T2D and examined experimental systems in which its mechanisms may be studied. Understanding these mechanisms may allow prevention of β-cell dedifferentiation or induction of cell redifferentiation for restoration of the functional β-cell mass. Stem Cells 2019;37:1267–1272.

Cite

CITATION STYLE

APA

Efrat, S. (2019). Beta-Cell Dedifferentiation in Type 2 Diabetes: Concise Review. Stem Cells, 37(10), 1267–1272. https://doi.org/10.1002/stem.3059

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free